This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Reference
Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117:1124–33.e1.
Author information
Authors and Affiliations
Contributions
All authors equally contributed to the conceptualization and creation of the visual abstract.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dychiao, R.G.K., Crisostomo, K.G.R., Magpantay, D.M.M. et al. Infographic: Ranibizumab for macular edema following central retinal vein occlusion (CRUISE). Eye (2024). https://doi.org/10.1038/s41433-024-02990-w
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-024-02990-w